Rapid screening of topoisomerase gene mutations by a novel melting curve analysis method for early warning of fluoroquinolone-resistant Streptococcus pneumoniae emergence

Journal of Clinical Microbiology

Volumn 44, Issue 12, 2006, Pages 4553-4558

  Fukushima, Kazuko Y ^a   Hirakata, Yoichi ^a   Sugahara, Kazuyuki ^a   Yanagihara, Katsunori ^a   Kondo, Akira ^a   Kohno, Shigeru ^a   Kamihira, Shimeru ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACCURACY; ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MELTING CURVE ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STREPTOCOCCUS PNEUMONIAE; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; DNA TOPOISOMERASES; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GENOTYPE; HUMANS; MUTATION; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; TRANSITION TEMPERATURE;

STREPTOCOCCUS PNEUMONIAE;

EID: 33845598189     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01887-06     Document Type: Article

References (29)

1. Alonso, R., M. Galimand, and P. Courvalin. 2004. An extended PCR-RFLP assay for detection of parC, parE, and gyrA mutations in fluoroquinolone- resistant Streptococcus pneumoniae. J. Antimicrob. Chemother. 53:682-683.
2. Bui, M. H., G. G. Stone, A. M. Nilius, L. Almer, and R. K. Flamm. 2003. PCR-oligonucleotide ligation assay for detection of point mutations associated with quinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:1456-1459.
3. Canton, R., M. Morosini, M. C. Enright, and I. Morrissey. 2003. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. J. Antimicrob. Chemother. 52:944-952.
4. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th edition. CLSI document M7-A7. Clinical and Laboratory Standards Institute, Wayne, Pa.
5. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, Pa.
6. Davidson, R., R. Cavalcanti, J. L. Brunton, D. J. Bast, J. C. Azavedo, P. Kibsey, C. Fleming, and D. E. Low. 2002. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N. Engl. J. Med. 346:747-750.
7. Doern, G. V., S. S. Richter, A. Miller, N. Miller, C. Rise, K. Heilmann, and S. Beekmann. 2005. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin. Infect. Dis. 41:139-148.
8. Eliopoulos, G. M. 2004. Quinolone resistance mechanisms in pnemococci. Clin. Infect. Dis. 38(Suppl. 4):S350-S356.
9. Endimiani, A., G. Brigante, A. A. Bettaccini, F. Luzzaro, P. Grossi, and A. Q. Toniolo. 2005. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia. BMC Infect. Dis. 5:106.
10. Felmingham, D., R. R. Reinert, Y. Hirakata, and A. Rodloff. 2002. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J. Antimicrob. Chemother. 50(Suppl. S1):25-37.
11. Gardam, M. A., and M. A. Miller. 1998. Optochin revisited: defining the optimal type of blood agar for presumptive identification of Streptococcus pneumoniae. J. Clin. Microbiol. 36:833-834.
12. Glocker, E., M. Berning, M. M. Gerrits, J. G. Kusters, and M. Kist. 2005. Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori. Antimicrob. Agents Chemother. 49:3166-3170.
13. Hooper, D. C. 2002. Fluoroquinolone resistance among gram positive cocci. Lancet Infect. Dis. 2:530-538.
14. Hooper, D. C. 1999. Mechanisms of fluoroquinolone resistance. Drug Resist. Updat. 2:38-55.
15. Ip, M., S. S. Chau, F. Chi, A. Qi, and R. W. Lai. 2006. Rapid screening of fluoroquinolone resistance determinants in Streptococcus pneumoniae by PCR-restriction fragment length polymorphism and single-strand conformational polymorphism. J. Clin. Microbiol. 44:970-975.
16. Lim, S., D. Bast, A. McGeer, J. de Azavedo, and D. E. Low. 2003. Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance. Emerg. Infect. Dis. 9:833-837.
17. Mandell, L. A., J. G. Bartlett, S. F. Dowell, T. M. File, Jr., D. M. Musher, and C. Whitney. 2003. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin. Infect. Dis. 37:1405-1433.
18. Muńoz, R., and A. G. de la Campa. 1996. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob. Agents Chemother. 40:2252-2257.
19. Niederman, M. S., L. A. Mandell, A. Anzueto, J. B. Bass, W. A. Broughton, G. D. Campbell, N. Dean, T. File, M. J. Fine, P. A. Gross, F. Martinez, T. J. Marrie, J. F. Plouffe, J. Ramirez, G. A. Sarosi, A. Torres, R. Wilson, and V. L. Yu. 2001. Guidelines for the management of adults with community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 163:1730-1754.
20. Pan, X. S., J. Ambler, S. Mehtar, and M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2321-2326.
21. Perez-Trallero, E., J. M. Marimon, L. Iglesias, and J. Larruskain. 2003. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates. Emerg. Infect. Dis. 9:1159-1162.
22. Richter, S. S., K. P. Heilmann, S. E. Beekman, N. J. Miller, C. L. Rice, and G. V. Doern. 2005. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations. Clin. Infect. Dis. 40:225-235.
23. Sheppard, C. L., T. G. Harrison, R. Morris, A. Horgan, and R. C. George. 2004. Autolysine-targeted LightCycler assay including internal process control for detection of Streptococcus pneumoniae DNA in clinical samples. J. Med. Microbiol. 53:189-195.
24. Tankovic, J., B. Perichon, J. Duval, and P. Courvalin. 1996. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro. Antimicrob. Agents Chemother. 40:2505-2510.
25. Vacher, S., A. Menard, E. Bernard, A. Santos, and F. Megraud. 2005. Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCR. Microb. Drug Resist. 11:40-47.
26. Vernel-Pauillac, F., V. Falcot, D. Whiley, and F. Merien. 2006. Rapid detection of a chromosomally mediated penicillin resistance-associated ponA mutation in Neisseria gonorrhoeae using a real-time PCR assay. FEMS Microbiol. Lett. 255:66-74.
27. Yamaguchi, K., and A. Ohno. 2005. Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002. Diagn. Microbiol. Infect. Dis. 52:135-143.
28. Yokota, S., K. Sato, O. Kuwahara, S. Habadera, N. Tsukamoto, H. Ohuchi, H. Akizawa, T. Himi, and N. Fujii. 2002. Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequency in elderly patients in Japan. Antimicrob. Agents Chemother. 46:3311-3315.
29. Yokota, S., K. Sato, S. Yoshida, and N. Fujii. 2004. Molecular epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae in Japan. Kansenshogaku Zasshi 78:428-434. (In Japanese.)